-
EARLY HEALTH ECONOMIC MODELING TO INFORM INTERVENTION AND TRIAL DESIGN OF COMPLEX PUBLIC HEALTH INTERVENTIONS: A CASE STUDY OF A COMMUNITY PHARMACIST LED HYPERTENSION INTERVENTION IN BANGLADESH AND PAKISTAN
Aug 11, 2026, 17:16 PM -
WHEN IS EXISTING PATIENT PREFERENCE INFORMATION FIT-FOR-REUSE? RECOMMENDATIONS FROM AN EDELPHI STUDY
Aug 11, 2026, 17:16 PM -
MACHINE LEARNING PREDICTION OF NON-INVASIVE VENTILATION FAILURE IN COPD: A TRIPOD-ALIGNED REAL-WORLD ANALYSIS
Aug 11, 2026, 17:16 PM -
REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS FOR CELL AND GENE THERAPIES IN EUROPE
Aug 11, 2026, 17:16 PM -
MODELING THE POTENTIAL PUBLIC HEALTH IMPACT OF INTRODUCING ONE-DOSE BOOSTER MENINGOCOCCAL B VACCINATION (4CMENB) FOR ADOLESCENTS IN ENGLAND, SPAIN AND ITALY
Aug 11, 2026, 17:16 PM -
A COST EFFECTIVENESS ANALYSIS OF NGS-BASED PANEL FOR BREAST CANCER PATIENTS IN EGYPT
Aug 11, 2026, 17:16 PM -
THE VALUE OF INVESTING IN HIV CARE IN THE NETHERLANDS: SOCIETAL GAIN AND REMAINING CHALLENGES
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGICAL, CLINICAL, ECONOMIC, AND HUMANISTIC BURDEN OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN THE UNITED ARAB EMIRATES: A MARKOV STATE-TRANSITION MODELING STUDY
Aug 11, 2026, 17:16 PM -
INTEGRATING DISCRETE CHOICE EXPERIMENT EVIDENCE INTO HEALTH ECONOMIC EVALUATIONS: A FRAMEWORK FOR PATIENT-CENTERED VALUE ASSESSMENT
Aug 11, 2026, 17:16 PM -
CONTENT VALIDITY AND PSYCHOMETRIC EVALUATION OF THE URTICARIA SYMPTOM DAILY DIARY (USDD) IN CHRONIC INDUCIBLE URTICARIA
Aug 11, 2026, 17:16 PM -
FROM REAL-WORLD DATA (RWD) TO IN-SILICO DESIGN: AN INTEGRATED APPROACH TO OPTIMISE STUDY DESIGN AND DECISION MAKING
Aug 11, 2026, 17:16 PM -
SYMPTOM BURDEN IN BRONCHIECTASIS: RESULTS OF A TARGETED LITERATURE REVIEW AND PATIENT FOCUS GROUPS
Aug 11, 2026, 17:16 PM -
THE MISSING STEM OF THE VALUE FLOWER: HTA IMPLICATIONS WHEN REAL-WORLD VALUE DEPENDS ON SUPPLY-CONSTRAINED HEALTH SYSTEMS
Aug 11, 2026, 17:16 PM -
AN AI-AUGMENTED INTERACTIVE R SHINY TOOL FOR AUTOMATED KAPLAN-MEIER RECONSTRUCTION, PARAMETRIC EXTRAPOLATION, AND HEALTH ECONOMIC EVALUATION
Aug 11, 2026, 17:16 PM -
IMPLICATIONS OF SEX-BASED HETEROGENEITY FOR INTERPRETING REAL-WORLD DISEASE BURDEN IN MYASTHENIA GRAVIS
Aug 11, 2026, 17:16 PM -
A MULTI-COUNTRY EVALUATION OF ACCESS TO BIOLOGICS FOR ATOPIC DERMATITIS IN EUROPE: EVIDENCE FROM THE LEBRIKIZUMAB CASE STUDY
Aug 11, 2026, 17:16 PM -
CURRENT GENAI POLICY IN HTA: THE MISSING MANDATE AND IMPLICATIONS FOR INDUSTRY
Aug 11, 2026, 17:16 PM -
WHY DO SIMILAR CLINICAL DATA RESULT IN DIFFERENT HTA CONCLUSIONS AND REIMBURSEMENT DECISIONS? THE CASE OF SEMAGLUTIDE AND TIRZEPATIDE IN OBESITY
Aug 11, 2026, 17:16 PM -
INCORPORATING THE EFFECTS OF PHARMACEUTICAL WATER POLLUTION INTO A HEALTH TECHNOLOGY ASSESSMENT: AN INTERREG-NWE PREWAPHARM (PREVENTION OF WATER POLLUTION BY PHARMACEUTICALS) PROJECT
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATIONS OF INTERVENTIONS FOR MULTIPLE LONG-TERM CONDITIONS: A SYSTEMATIC REVIEW OF GLOBAL EVIDENCE
Aug 11, 2026, 17:16 PM
